KCNK2 and migraine disorder: Using behavioral tests in wild-type and double knock-out mice for Trek1/Trek2 (Trek1−/−-Trek2−/− mice), we demonstrate that ML67-33 reverses the NO donor-induced migraine-like phenotype.